Latest News about LLY
Recent news which mentions LLY
From Benzinga
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
July 26, 2024
From Benzinga
Walt Disney, Eli Lilly, AST SpaceMobile, DexCom, Tesla: Why These 5 Stocks Are On Investors' Radars Today
July 25, 2024
From Benzinga
From Motley Fool
7 Explosive Growth Stocks Set to Soar in 2024
July 25, 2024
From InvestorPlace
Novo Nordisk Shares Decline Amid Competitive Pressure
July 25, 2024
From Benzinga
3 Top-Performing Stocks Beating the Big Names in 2024
July 25, 2024
From InvestorPlace
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
July 25, 2024
From Benzinga
From Benzinga
3 Companies Gearing Up for a Stock Split
July 25, 2024
From InvestorPlace
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years
July 25, 2024
From Benzinga
From InvestorPlace
From Benzinga
3 Fabulous Growth Stocks to Buy and Hold Forever
July 24, 2024
From InvestorPlace
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
July 24, 2024
From Benzinga
From Motley Fool
If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today
July 24, 2024
Tickers
LLY
From Motley Fool
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
July 23, 2024
From Motley Fool
Don’t Delay! 3 Stocks to Buy BEFORE Q2 Earnings.
July 22, 2024
From InvestorPlace
Biden's Exit From Presidential Race 'Yet Another Curveball For Equity Investors': Analysts
July 22, 2024
From Benzinga
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
July 22, 2024
From Benzinga
From Benzinga
From Motley Fool
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
July 21, 2024
From Motley Fool
Craze For Ozempic And Zepbound For Weight Loss Leave Diabetic Patients Without Critical GLP-1 Medications
July 19, 2024
From Benzinga
From Benzinga
Is Viking Therapeutics a Millionaire-Maker?
July 19, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.